HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

4th Edition of

International Ophthalmology Conference

March 23-25, 2026 | Singapore

Translational and Experimental Ophthalmology

Translational and Experimental Ophthalmology

Translational and experimental ophthalmology bridges the gap between laboratory research and clinical practice, turning scientific discoveries into practical treatments. By focusing on innovative research, this field seeks to translate basic science into real-world applications, offering new treatments for ocular diseases such as retinal degeneration, corneal disorders, and optic neuropathies. Advances in gene therapy, stem cell research, and novel drug delivery systems are among the key areas driving progress. This research is crucial for improving treatments for conditions like age-related macular degeneration, where conventional therapies often fall short. Translational efforts are not only focused on developing new therapies but also on optimizing current treatment protocols to improve patient outcomes. The ultimate goal is to improve patient care by integrating cutting-edge scientific findings into clinical practice, offering hope for individuals with conditions that were once considered untreatable.

Committee Members
Speaker at International Ophthalmology Conference 2026 - Shadrokh Nabili

Shadrokh Nabili

University Hospitals of Morecambe Bay NHS Foundation Trust, United Kingdom
Speaker at International Ophthalmology Conference 2026 - Magali Taiel

Magali Taiel

GenSight Biologics, France
Speaker at International Ophthalmology Conference 2026 - Pio Conti

Pio Conti

University of Chieti, Italy
Tags

Submit your abstract Today

Watsapp